该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-05-03 AccNo: 0001564590-18-010482 Size: 1 MBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 美东时间 2018-05-03 盘前 披露财报,预期EPS 0.5 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-04-27 AccNo: 0001564590-18-009425 Size: 50 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$凯姆布雷克斯(CBM)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-19 AccNo: 0001564590-18-008488 Size: 40 KB 网页链接
$凯姆布雷克斯(CBM)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-16 AccNo: 0001564590-18-005938 Size: 2 MB 网页链接
$凯姆布雷克斯(CBM)$ 内部交易: 2018-02-12,Director,DIXON ROSINA B ,期权,20656普通股, $26.67
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0001144204-18-007808 Size: 54 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-08 AccNo: 0000932471-18-002989 Size: 45 KB 网页链接
$凯姆布雷克斯(CBM)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-08 AccNo: 0001437749-18-001987 Size: 11 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-02-08 AccNo: 0001437749-18-001981 Size: 404 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接